- Home
- LIXT vs XAGE Comparison
LIXT vs XAGE Comparison
Compare LIXT & XAGE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LIXT
- XAGE
- Stock Information
- Founded
- LIXT 2005
- XAGE 2008
- Country
- LIXT United States
- XAGE United States
- Employees
- LIXT N/A
- XAGE N/A
- Industry
- LIXT Biotechnology: Pharmaceutical Preparations
- XAGE
- Sector
- LIXT Health Care
- XAGE
- Exchange
- LIXT Nasdaq
- XAGE NYSE
- Market Cap
- LIXT 3.0M
- XAGE 2.6M
- IPO Year
- LIXT N/A
- XAGE N/A
- Fundamental
- Price
- LIXT $0.74
- XAGE $2.57
- Analyst Decision
- LIXT
- XAGE
- Analyst Count
- LIXT 0
- XAGE 0
- Target Price
- LIXT N/A
- XAGE N/A
- AVG Volume (30 Days)
- LIXT 82.2K
- XAGE 95.1K
- Earning Date
- LIXT 08-07-2025
- XAGE 08-13-2025
- Dividend Yield
- LIXT N/A
- XAGE N/A
- EPS Growth
- LIXT N/A
- XAGE N/A
- EPS
- LIXT N/A
- XAGE N/A
- Revenue
- LIXT N/A
- XAGE $560,671.00
- Revenue This Year
- LIXT N/A
- XAGE N/A
- Revenue Next Year
- LIXT N/A
- XAGE N/A
- P/E Ratio
- LIXT N/A
- XAGE N/A
- Revenue Growth
- LIXT N/A
- XAGE N/A
- 52 Week Low
- LIXT $0.64
- XAGE $2.20
- 52 Week High
- LIXT $3.00
- XAGE $59.70
- Technical
- Relative Strength Index (RSI)
- LIXT 30.79
- XAGE N/A
- Support Level
- LIXT $0.64
- XAGE N/A
- Resistance Level
- LIXT $0.93
- XAGE N/A
- Average True Range (ATR)
- LIXT 0.13
- XAGE 0.00
- MACD
- LIXT -0.05
- XAGE 0.00
- Stochastic Oscillator
- LIXT 16.99
- XAGE 0.00
About LIXT Lixte Biotechnology Holdings Inc.
Lixte Biotechnology Holdings Inc is a biopharmaceutical company dedicated to improving patients' lives by developing a drug class called Protein Phosphatase 2A inhibitors. Its product pipeline is focused on inhibitors of protein phosphatase 2A, used in combination with cytotoxic agents and/or x-rays, immune checkpoint blockers, and other cancer therapies. The Company believes that inhibitors of protein phosphatases have therapeutic potential for a broad range of cancers. It focuses on the clinical development of a specific protein phosphatase inhibitor, referred to as LB-100, which has been shown to have clinical anti-cancer activity at doses that produce little or no toxicity.
About XAGE LONGEVITY HEALTH HLDGS INC
Longevity Health Holdings Inc is a United States based bio-aesthetics company focused on developing, manufacturing, and marketing cosmetic skincare and haircare products. The company has two cosmetic product lines, Carmell Secretome and Elevai Exosomes, that support skin and hair health.